AMN logo

AMN HEALTHCARE SERVICES INC

AMNNYSE
πŸ† #2281 by market capEarnings Oct 29 Β· PostUS Equity
$678.68β–² $11.20 (+1.65%)
Simulated price
πŸ””
Track AMN
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 1.6%
7dβ–² 1857.0%
14dβ–² 1892.0%
30dβ–² 1860.1%
ytdβ–² 4203.6%
1yβ–² 3567.5%
🏦Market Cap
$1.34B
Small Cap
πŸ“ˆRevenue Growth (YoY)
-8.5%
Declining
πŸ“ŠGross Margin
27.8%
Moderate
πŸ’΅FCF Margin
12.8%
Healthy
βš–οΈP/S Ratio
0.4x
Cheap
Otter Score
52
Weak

Trading Snapshot

Day Range
$671.98 – $689.62
52-Week Range
$14.97 – $37.22
Volume
$2.87B
Avg Volume
$2.99B
Shares Outstanding
38.8M
Next Earnings
Dec 4, 2026

Fundamentals Snapshot

Annual Revenue
$2.73B
Last Q Revenue
$673M
P/E Ratio
12.8
P/S Ratio
0.4x
EPS (TTM)
$2.69
Dividend Yield
0.00%
Dilution (1yr)
+1.2%

Why Investors Own AMN

  • βœ“High-growth profile β€” revenue up -5.2% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 65% gross margin and 9% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

AMN logo

AMN HEALTHCARE SERVICES INC

AMN
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$2.7Bβ–Ό βˆ’8.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
28.3%β–Ό βˆ’8.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$33Mβ–Ό βˆ’132.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$234Mβ–Ό βˆ’2.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
38.7Mβ–² +1.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$769Mβ–² +$318M YoY
StockOtter Β· stockotter.space

About AMN HEALTHCARE SERVICES INC

AMN Healthcare Services, Inc. (AMN) specializes in delivering comprehensive workforce solutions and staffing services to hospitals and healthcare facilities throughout the United States. Its operations are structured across three primary segments: The Nurse and Allied Solutions segment focuses on placing registered nurses in travel assignments, rapid response roles during emergencies or labor disruptions, and local positions. It also supplies allied health professionals for various roles and offers revenue cycle management solutions. Through its Physician and Leadership Solutions segment, AMN facilitates the placement of locum tenens physicians for temporary assignments, provides interim leadership for healthcare organizations, conducts executive searches, and handles permanent physician recruitment. Lastly, the Technology and Workforce Solutions segment encompasses services like language interpretation, vendor management systems (VMS), workforce optimization strategies, telehealth platforms, credentialing assistance, and various outsourced solutions. Beyond nurses and physicians, AMN's network of professionals includes a broad spectrum of allied health specialists such as physical, respiratory, and occupational therapists; medical and radiology technologists; lab technicians; speech pathologists; rehabilitation assistants; and pharmacists. The company leverages numerous recognized brands to deliver its services, including American Mobile, Nursefinders, NurseChoice, HealthSource Global Staffing, Onward Healthcare, O'Grady Peyton International, Med Travelers, Club Staffing, Staff Care, B.E. Smith, Merritt Hawkins, AMN Revenue Cycle Solutions, and AMN Language Services. Established in 1985, AMN Healthcare is headquartered in Dallas, Texas.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
52/100

Analyst Price Target

β“˜
Average Target
$842.84
β–² +24.2% Upside
High Target$1,044.22
Low Target$702.63
Based on 17 analysts

Latest News & Updates